Keywords: ipsen, nine-months, sales, up, paris, france-headquartered, says
Ipsen nine-months sales up 8.8%
Article | 06 November 2006
Paris, France-headquartered Ipsen says that sales for the first nine months of 2006 increased 7.3% to 651.2 million euros ($817.1 million), with targeted therapeutics ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
